A Study of SHR-1314 in Healthy Subjects

NCT02934412 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: SHR-1314
DRUG: placebo

Sponsor

Atridia Pty Ltd.